Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Bioorg Chem ; 95: 103527, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31911298

RESUMO

Diabetes mellitus (DM) is a serious chronic metabolic disorder which occurs due to dysfunction of insulin and therapeutic approaches are poor. It is an under estimation that 387 million people currently suffering globally with diabetic and more than 592 million people may be affected by 2030. It makes an urgent necessity to discover novel drugs to control amplified diabetic populations. In this study, amino chalcones (3a-j) were synthesized and hydroxy chalcones (3g-j) were isolated from natural source such as Sophora interrupta, Clerodendrum phlomidis and Andrographis macrobotrys. Structural elucidation was carried out using Mass, 1H and 13C NMR Spectra. In vivo studies were carried out with alloxan induced diabetic rats (100 mg/kg) which reveals compounds 3c, 3a and 3h have significant antidiabetic efficacy with decreased blood glucose levels in the diabetic rats while compared with control rats. Besides, docking studies with aldose reductase, dipeptidyl peptidase, PPAR and glucosidase were monitored which accomplishes that the compounds 3c, 3i, 3a and 3d have eloquent binding affinity (kcal/mol) with aldose reductase, besides the chalcones 3c, 3b, 3d, 3e and 3i were also showed inhibition with DPP-IV, PPAR-α and α-glucosidase. Also, these compounds explicated distinct interactions i.e., π-π, π-cationic, polar, electrostatic and hydrophobic bonds were observed with key residues of binding pockets. Bioavailability is disclosed with Lipinski rule of five and the design pharmacokinetic as well as pharmacodynamic properties are reliable. Therefore, chalcones were implied as antidiabetic leads for in further studies and could be worthwhile for the development of new classes of effective antidiabetic agents.


Assuntos
Chalconas/uso terapêutico , Diabetes Mellitus Experimental/tratamento farmacológico , Desenho de Fármacos , Hipoglicemiantes/uso terapêutico , Animais , Disponibilidade Biológica , Chalconas/farmacocinética , Avaliação Pré-Clínica de Medicamentos , Hipoglicemiantes/farmacocinética , Simulação de Acoplamento Molecular , Ratos
2.
Microb Pathog ; 136: 103667, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31419459

RESUMO

Rhynchosia beddomei Baker (R. beddomei) is a viscous hairy under shrub, belongs to the family of Fabaceae and widely distributed in Deccan and Carnatic regions of South India. In the present investigation, four flavonoids such as an isoflavone, 5,7-dihydroxy-4'-methoxyisoflavone (RB-1), a flavonol, quercetin-7-O-methylether (RB-2), two flavone C-glycosides, isovitexin (RB-3) and 5,7,3',4'-tetrahydroxy-6-C-ß-d-glucopyranosyl flavone (RB-4) were isolated from the flowers of R. beddomei Baker through bioassay guided fractionation. Subsequently, antimicrobial activity of compounds against drug resistant gram positive and negative bacteria and fungi revealed RB-2 and RB-4 have shown highest minimal inhibition concentrations against Pseudomonas aeruginosa and Candida albicans. RB-2 and RB-4 enclosed OH groups at 5th position on the ring A, 3' and 4' ortho dihydroxyl groups positioned on the ring B and accomplished efficacious antibacterial activity. In addition, Docking studies perceptible that RB-4 conferred highest binding energy of -10.5 kcal/mol and exhibited eloquent polar and non-polar interactions with active site residues of N-Myristoyltransferase (Nmt) of Candida albicans while binding energy of -7.5 kcal/mol was recorded for peptidyldeformylase (PaPDF) of Pseudomonas aeruginosa. Moreover, these compounds obey Lipinski's rule of five and exerts good drug likeness properties and might be ratified as lead molecules for further investigations to prevent panicking microbial infections.


Assuntos
Anti-Infecciosos/farmacologia , Fabaceae/química , Flavonoides/farmacologia , Flores/química , Compostos Fitoquímicos/farmacologia , Anti-Infecciosos/isolamento & purificação , Bioensaio , Candida albicans/efeitos dos fármacos , Flavonoides/isolamento & purificação , Bactérias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Positivas/efeitos dos fármacos , Índia , Simulação de Acoplamento Molecular , Compostos Fitoquímicos/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...